NDC 65219-084 – Gadoterate Meglumine
Gadoterate Meglumine 376.9 mg/mL · Injection · Intravenous
Product NDC65219-084
Product details
- Brand name
- Gadoterate Meglumine
- Generic name
- Gadoterate meglumine
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA215304
- Marketed since
- June 20, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Gadolinium-based Contrast Agent
Active ingredients
- Gadoterate Meglumine 376.9 mg/mL
Uses, dosage, side effects and warnings for Gadoterate Meglumine →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 65219-084-15 | 10 CARTON in 1 BOX (65219-084-15) / 1 VIAL in 1 CARTON (65219-084-01) / 15 mL in 1 VIAL | Jun 20, 2022 |
Other Gadoterate Meglumine products
- 65219-080 Gadoterate Meglumine 376.9 mg/mL · Injection · Fresenius Kabi USA, LLC
- 65219-082 Gadoterate Meglumine 376.9 mg/mL · Injection · Fresenius Kabi USA, LLC
- 65219-086 Gadoterate Meglumine 376.9 mg/mL · Injection · Fresenius Kabi USA, LLC
- 65219-088 Gadoterate Meglumine 376.9 mg/mL · Injection · Fresenius Kabi USA, LLC
- 70436-123 Gadoterate Meglumine 376.9 mg/mL · Injection · Slate Run Pharmaceuticals, LLC